MassCheck® Neuroleptics 1/EXTENDED Plasma Controls

Order No.: 0210/XT; 0211/XT; 0212/XT
Parameters:
9-OH-Risperidone, Aripiprazole, Clozapine, Dehydroaripiprazole, Haloperidol, N-Desmethylclozapine, N-Desmethylolanzapine, Norquetiapine, Olanzapine, Quetiapine, Risperidone
MassTox® TDM Series A Neuroleptics 1/EXTENDED in Serum/Plasma – LC-MS/MS
Grouped product items
Product Name Qty
MassCheck® Neuroleptics 1/EXTENDED Plasma Control, Level I
Order No.: 0211/XT
MassCheck® Neuroleptics 1/EXTENDED Plasma Control, Level II
Order No.: 0212/XT
MassCheck® Neuroleptics 1/EXTENDED Plasma Control, Bi-Level (I+II)
Order No.: 0210/XT

Aripiprazole

Dehydroaripiprazole

Clozapine

N-Desmethylclozapine

Haloperidol

Olanzapine

N-Desmethylolanzapine

Quetiapine

Norquetiapine

Risperidone

9-OH-Risperidone

MassCheck® Neuroleptics 1/EXTENDED Plasma Controls

For MassTox® TDM Series A Parameter Set Neuroleptics 1/EXTENDED in Serum/Plasma by LC-MS/MS (92912/XT)

0210/XT MassCheck® Neuroleptics 1/EXTENDED Plasma Control, Bi-Level I + II (lyoph.), 2 x 5 x 1 ml
0211/XT MassCheck® Neuroleptics 1/EXTENDED Plasma Control, Level I (lyoph.), 5 x 1 ml
0212/XT MassCheck® Neuroleptics 1/EXTENDED Plasma Control, Level II (lyoph.), 5 x 1 ml

These lyophilised quality controls from Chromsystems are based on human plasma and should be used according to the instruction manual. They are designed to monitor the accuracy and precision of analytical procedures in clinical diagnostics for the quantitative determination of neuroleptics 1/EXTENDED in serum/plasma. While following the instructions the controls should be handled and measured in the same manner as a patient specimen.

More Information
Concentrations

Please note: All concentrations shown here are exemplatory. They do not reflect real data for the described products. Actual concentrations depend on the production lot of each product and can exclusively be found in the product information leaflet. Please ask for these product information leaflets or download them for your convenience.

NEW: An Excel file with the data from the product information leaflet is now available in the "Downloads" section (for registered customers only). This eliminates manual data entry of large data sets.

SubstanceValue [µg/l]
Level I
Range [µg/l]
Level I
Value [µg/l]
Level II
Range [µg/l]
Level II
Aripiprazole 163 130-195 302 241-362
Dehydroaripiprazole 65.5 52.4-78.6 121 97.1-146
Clozapine 336 269-403 568 455-682
Desmethylclozapine 162 129-194 228 183-274
Haloperidol 4.06 3.25-4.87 18.0 14.4-21.7
Olanzapine 36.5 29.2-43.8 65.9 52.8-79.1
N-Desmethylolanzapine 39.2 31.4-47.0 71.1 56.9-85.3
Quetiapine 63.1 50.4-75.7 260 208-311
Norquetiapine 23.9 19.1-28.6 97.5 78.0-117
Risperidone 8.79 7.03-10.6 13.6 10.9-16.3
9-OH-Risperidone 40.5 32.4-48.6 75.6 60.5-90.7
Method of Analysis LC-MS/MS
Parameters 9-OH-Risperidone, Aripiprazole, Clozapine, Dehydroaripiprazole, Haloperidol, N-Desmethylclozapine, N-Desmethylolanzapine, Norquetiapine, Olanzapine, Quetiapine, Risperidone
As a customer please login or register to gain full access.

Aripiprazole

Dehydroaripiprazole

Clozapine

N-Desmethylclozapine

Haloperidol

Olanzapine

N-Desmethylolanzapine

Quetiapine

Norquetiapine

Risperidone

9-OH-Risperidone

MassCheck® Neuroleptics 1/EXTENDED Plasma Controls

For MassTox® TDM Series A Parameter Set Neuroleptics 1/EXTENDED in Serum/Plasma by LC-MS/MS (92912/XT)

0210/XT MassCheck® Neuroleptics 1/EXTENDED Plasma Control, Bi-Level I + II (lyoph.), 2 x 5 x 1 ml
0211/XT MassCheck® Neuroleptics 1/EXTENDED Plasma Control, Level I (lyoph.), 5 x 1 ml
0212/XT MassCheck® Neuroleptics 1/EXTENDED Plasma Control, Level II (lyoph.), 5 x 1 ml

These lyophilised quality controls from Chromsystems are based on human plasma and should be used according to the instruction manual. They are designed to monitor the accuracy and precision of analytical procedures in clinical diagnostics for the quantitative determination of neuroleptics 1/EXTENDED in serum/plasma. While following the instructions the controls should be handled and measured in the same manner as a patient specimen.

More Information
Concentrations

Please note: All concentrations shown here are exemplatory. They do not reflect real data for the described products. Actual concentrations depend on the production lot of each product and can exclusively be found in the product information leaflet. Please ask for these product information leaflets or download them for your convenience.

NEW: An Excel file with the data from the product information leaflet is now available in the "Downloads" section (for registered customers only). This eliminates manual data entry of large data sets.

SubstanceValue [µg/l]
Level I
Range [µg/l]
Level I
Value [µg/l]
Level II
Range [µg/l]
Level II
Aripiprazole 163 130-195 302 241-362
Dehydroaripiprazole 65.5 52.4-78.6 121 97.1-146
Clozapine 336 269-403 568 455-682
Desmethylclozapine 162 129-194 228 183-274
Haloperidol 4.06 3.25-4.87 18.0 14.4-21.7
Olanzapine 36.5 29.2-43.8 65.9 52.8-79.1
N-Desmethylolanzapine 39.2 31.4-47.0 71.1 56.9-85.3
Quetiapine 63.1 50.4-75.7 260 208-311
Norquetiapine 23.9 19.1-28.6 97.5 78.0-117
Risperidone 8.79 7.03-10.6 13.6 10.9-16.3
9-OH-Risperidone 40.5 32.4-48.6 75.6 60.5-90.7
Method of Analysis LC-MS/MS
Parameters 9-OH-Risperidone, Aripiprazole, Clozapine, Dehydroaripiprazole, Haloperidol, N-Desmethylclozapine, N-Desmethylolanzapine, Norquetiapine, Olanzapine, Quetiapine, Risperidone
As a customer please login or register to gain full access.